OCUSULF-30 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ocusulf-30, and when can generic versions of Ocusulf-30 launch?
Ocusulf-30 is a drug marketed by Miza Pharms Usa and is included in one NDA.
The generic ingredient in OCUSULF-30 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ocusulf-30
A generic version of OCUSULF-30 was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUSULF-30?
- What are the global sales for OCUSULF-30?
- What is Average Wholesale Price for OCUSULF-30?
Summary for OCUSULF-30
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Patent Applications: | 819 |
| DailyMed Link: | OCUSULF-30 at DailyMed |
US Patents and Regulatory Information for OCUSULF-30
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Miza Pharms Usa | OCUSULF-30 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080660-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
